Session » Epidemiology and Public Health - Poster II
-
Abstract Number: 1167
Incidence of Primary Chronic Cutaneous Lupus Erythematosus in a Metropolitan Area of the Southeastern United States: The Georgia Lupus Registry
-
Abstract Number: 1168
The Epidemiology of Individuals Not Fully Meeting Classification Criteria for Systemic Lupus Erythematosus (SLE): The Georgia Lupus Registry
-
Abstract Number: 1169
A Systematic Review of Rheumatic Disease Epidemiology in the Indigenous Populations of Canada, the United States, Australia and New Zealand
-
Abstract Number: 1170
Month of Birth Affects the Risk of Rheumatic Diseases: A Nationwide Case-Control Study
-
Abstract Number: 1171
Obesity and the Risk of Systemic Lupus Erythematosus in the Nurses’ Health Studies
-
Abstract Number: 1172
Azathioprine and Mycophenolate Mofetil Adherence in a Nationwide Medicaid Cohort with Systemic Lupus Erythematosus
-
Abstract Number: 1173
Screening for Depression and Anxiety in an Outpatient Rheumatology Clinic Using Validated Self-Applied Questionnaires
-
Abstract Number: 1174
Perceived Stress and Reported Cognitive Symptoms Among Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1175
Thirty Day Readmission Rates for Patients Diagnosed with Systemic Lupus Erythematosus: Analysis at a Tertiary Care Center
-
Abstract Number: 1177
Pneumocystis Jirovecii Pneumonia in Systemic Autoimmune Inflammatory Diseases
-
Abstract Number: 1178
Is Subclinical Atherosclerosis Prevalent in a French Patient Cohort with Systemic Lupus Erythematosus?
-
Abstract Number: 1179
The Impact of Autoimmune Disease in the Management and Prognosis of Acute Coronary Syndrome
-
Abstract Number: 1180
Class V Lupus Nephritis Results in Significant Numbers of End Stage Renal Disease and Death in a Population-Based Registry
-
Abstract Number: 1181
Risk Factors for Incident Fractures in Patients with Systemic Lupus Erythematosus on Dialysis
-
Abstract Number: 1182
Opiod Use and Death in Chronic Pain Patients with Systemic Lupus Erythematosis
-
Abstract Number: 1183
Lack of Awareness of Sexual Health in Rheumatology. High Prevalence of Sexual Dysfunction Among Women with Rheumatic Diseases
-
Abstract Number: 1184
Projected 2015 Prevalence of Physician-Diagnosed Primary SjöGren’s Syndrome Based on 1976-2005 Annual Incidence Rates in a Well-Defined U.S. Population
-
Abstract Number: 1185
Increased Risk of Osteoporotic Fractures in Patients with Primary SjöGren Syndrome: A Nationwide Population-Based Study in Taiwan
-
Abstract Number: 1186
The Use of Clinical Mucosal Manifestations to Differentiate Patients with Lupus and Dermatomyositis: Transversal, Retrospective and Analytical Study of 116 Patients
-
Abstract Number: 1187
Ultraviolet Radiation Exposures Are Associated with Dermatomyositis in a National Myositis Registry
-
Abstract Number: 1188
Major Comorbidities of Idiopathic Inflammatory Myositis: A Population-Based Study Using 10 Years of Follow up from the National Health Insurance in Korea
-
Abstract Number: 1189
Inpatient Trends for Adults with Scleroderma in the United States: A 20 Year Analysis
-
Abstract Number: 1190
Incidence and Prevalence of Polymyalgia Rheumatic and Giant Cell Arteritis: A 15-Year Study in a Health Care Management Organization
-
Abstract Number: 1191
Retinal Vessel Morphometry Associations with Polymyalgia Rheumatica; Findings from the European Prospective Investigation of Cancer (EPIC) in Norfolk
-
Abstract Number: 1192
Mortality and Survival of Patients Diagnosed with GCA in Bergen (Western Norway) 1972-2012
-
Abstract Number: 1193
Mortality Rate According to Cause in Patients with Hemophagocytic Lymphohistiocytosis: A Meta-Analysis
-
Abstract Number: 1194
Low Body Mass Index and Smoking Are Associated with a Lower Risk of Sarcoidosis: A Population-Based Nested Case-Control Study
-
Abstract Number: 1195
Risk of Hospitalized Infection Among Patients with Sarcoidosis: A Population-Based Retrospective Cohort Study
-
Abstract Number: 1196
AA Amyloidosis: An Evaluation of Epidemiology and Prevalence in the US and EU5 Countries